Design: A prospective observational study.
Study Sample: The study included 885 first-time and 330 experienced hearing aid (HA) users with a valid real-ear measurement on both ears and answers to the abbreviated version of the Speech, Spatial, and Quality of Hearing (SSQ12) and the International Outcome Inventory for Hearing Aids (IOI-HA) questionnaires.
Results: K-means clustering of gain differences between individual real-ear insertion gain to three generic gain prescriptions (NAL-NL2, NAL-RP, and one-third gain rules) was performed. The gain difference at higher frequencies generally differentiated the clusters. The experienced users in the cluster with fittings closest to NAL-NL2 and NAL-RP prescription were found to exhibit a higher IOI-HA Factor 1 score (representing the overall benefit of the hearing aid use). The gain differences to generic prescription did not affect other self-reported outcomes for first-time and experienced HA
Conclusion: The experienced HA users with minimal gain deviations from generic prescriptions reported better self-perceived benefits than users with larger deviations. However, this was not apparent in first-time users.
FingeraftrykDyk ned i forskningsemnerne om 'Can Real-Ear Insertion Gain Deviations from Generic Fitting Prescriptions Predict Self-Reported Outcomes?'. Sammen danner de et unikt fingeraftryk.
Can real-ear insertion gain deviations from generic fitting prescriptions predict self-reported outcomes?
Narayanan, S. K. (Ophavsperson), Rye, P. (Ophavsperson), Piechowiak, T. (Ophavsperson), Ravn, G. (Ophavsperson), Wolff, A. (Ophavsperson), Houmøller, S. S. (Ophavsperson), Schmidt, J. H. (Ophavsperson) & Hammershøi, D. (Ophavsperson), Taylor & Francis, 2022